Similar Search Results

The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany

Blankart, Katharina; Stargardt, Tom - In: Health Economics 29 (2020) S1, pp. 63-82

Persistent link: https://www.econbiz.de/10012273083

The diffusion of generics after patent expiry in Germany

Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040

Persistent link: https://www.econbiz.de/10011660160

The impact of physician-level drug budgets on prescribing behavior

Blankart, Katharina; Koch, Taika; Kostev, Karel; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 213-222

Persistent link: https://www.econbiz.de/10011946212

The Effects of Off-label Drug Use on Disability and Medical Expenditure

Blankart, Katharina; Lichtenberg, Frank R. - National Bureau of Economic Research - 2022

Does using prescription drugs off-label increase disability and medical expenditure? This paper uses a unique dataset to evaluate off-label vs. on-label drug use in the US non-institutionalized population. Patients using drugs off-label have on average $515 higher medical expenditure and...

Persistent link: https://www.econbiz.de/10013388796